Evaluation of Antibody Response to Heterologous Prime-Boost Vaccination with ChAdOx1 nCoV-19 and BNT162b2: An Observational Study.
Davide FirinuAndrea PerraMarcello CampagnaRoberto LitteraFederico MeloniFrancesca SeddaMaria ContiGiulia Anna Maria Luigia CostanzoMonica ErbiGianmario UsaiCarlotta LocciMauro Giovanni CartaRiccardo CappaiGermano OrrùStefano R Del GiaccoFerdinando CogheLuchino ChessaPublished in: Vaccines (2021)
Our data highlight the magnitude of IgG anti-S-RBD response in ChAd/BNT dosing, supporting the current national guidelines for heterologous boosting.